Mersana Therapeutics Statistics
Total Valuation
MRSN has a market cap or net worth of $40.87 million. The enterprise value is -$16.43 million.
Important Dates
The next estimated earnings date is Wednesday, November 12, 2025, before market open.
| Earnings Date | Nov 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
MRSN has 4.99 million shares outstanding. The number of shares has increased by 2.12% in one year.
| Current Share Class | 4.99M |
| Shares Outstanding | 4.99M |
| Shares Change (YoY) | +2.12% |
| Shares Change (QoQ) | +0.16% |
| Owned by Insiders (%) | 2.06% |
| Owned by Institutions (%) | 42.56% |
| Float | 4.06M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.14 |
| Forward PS | 1.58 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.35
| Current Ratio | 1.35 |
| Quick Ratio | 1.30 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -21.56 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -34.11% |
| Return on Invested Capital (ROIC) | -1,018.24% |
| Return on Capital Employed (ROCE) | -285.20% |
| Revenue Per Employee | $340,873 |
| Profits Per Employee | -$725,853 |
| Employee Count | 102 |
| Asset Turnover | 0.26 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, MRSN has paid $418,000 in taxes.
| Income Tax | 418,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -84.10% in the last 52 weeks. The beta is 0.88, so MRSN's price volatility has been lower than the market average.
| Beta (5Y) | 0.88 |
| 52-Week Price Change | -84.10% |
| 50-Day Moving Average | 7.23 |
| 200-Day Moving Average | 12.13 |
| Relative Strength Index (RSI) | 63.29 |
| Average Volume (20 Days) | 41,826 |
Short Selling Information
The latest short interest is 426,625, so 8.55% of the outstanding shares have been sold short.
| Short Interest | 426,625 |
| Short Previous Month | 433,286 |
| Short % of Shares Out | 8.55% |
| Short % of Float | 10.51% |
| Short Ratio (days to cover) | 6.20 |
Income Statement
In the last 12 months, MRSN had revenue of $34.77 million and -$74.04 million in losses. Loss per share was -$14.94.
| Revenue | 34.77M |
| Gross Profit | -36.88M |
| Operating Income | -71.97M |
| Pretax Income | -73.62M |
| Net Income | -74.04M |
| EBITDA | -70.56M |
| EBIT | -71.97M |
| Loss Per Share | -$14.94 |
Full Income StatementBalance Sheet
The company has $76.97 million in cash and $20.62 million in debt, giving a net cash position of $56.35 million or $11.29 per share.
| Cash & Cash Equivalents | 76.97M |
| Total Debt | 20.62M |
| Net Cash | 56.35M |
| Net Cash Per Share | $11.29 |
| Equity (Book Value) | -53.15M |
| Book Value Per Share | -10.65 |
| Working Capital | 20.80M |
Full Balance SheetCash Flow
| Operating Cash Flow | -79.76M |
| Capital Expenditures | n/a |
| Free Cash Flow | -79.76M |
| FCF Per Share | -$15.98 |
Full Cash Flow StatementMargins
Gross margin is -106.07%, with operating and profit margins of -206.99% and -212.94%.
| Gross Margin | -106.07% |
| Operating Margin | -206.99% |
| Pretax Margin | -211.74% |
| Profit Margin | -212.94% |
| EBITDA Margin | -202.95% |
| EBIT Margin | -206.99% |
| FCF Margin | n/a |
Dividends & Yields
MRSN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.12% |
| Shareholder Yield | -2.12% |
| Earnings Yield | -185.44% |
| FCF Yield | -199.76% |
Analyst Forecast
The average price target for MRSN is $33.00, which is 302.93% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $33.00 |
| Price Target Difference | 302.93% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 26.12% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on July 28, 2025. It was a reverse split with a ratio of 1:25.
| Last Split Date | Jul 28, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:25 |
Scores
MRSN has an Altman Z-Score of -17.08 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -17.08 |
| Piotroski F-Score | 2 |
